A Phase 2 Trial of AU-011, an Investigational, Virus-Like Drug Conjugate (VDC) for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma (IL/CM) using Suprachoroidal Administration
News Category: Presentations
Euretina 2021: Aura Clinical Data Presented
A Phase 2 Trial of AU-011for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma using Suprachoroidal Administration
ARVO 2021: Aura Clinical Data Presented
ARVO 2021: Aura Preclinical Data Presented
AAO 2020: Dr. Carol Shields Presents Overview of AU-011
AU-011, a Targeted Therapy for Primary Treatment of Choroidal Melanoma (CM) via Intravitreal (IVT) or Suprachoroidal (SC) Administration